Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Treatment for Herpes Zoster Ophthalmicus

First-Line Therapy

  • The American Academy of Ophthalmology recommends valacyclovir 1000 mg three times daily for 7 days as the preferred treatment for herpes zoster ophthalmicus due to its superior bioavailability and simpler dosing schedule compared to acyclovir 1
  • Alternative options include acyclovir 800 mg five times daily for 7 days and famciclovir 500 mg three times daily for 7 days 1

Adjunctive Therapy

  • Topical antibiotics may be used to prevent secondary bacterial infection of vesicles, and topical antivirals alone have not been shown to be helpful in treating VZV conjunctivitis but may be used as additive treatment in unresponsive patients 1, 2
  • Immunocompromised patients may need more aggressive treatment 1, 2
  • For chronic disease, prolonged treatment with adjustment of dose according to clinical response is recommended 1

Management of Complications

  • Involvement of an experienced ophthalmologist is strongly recommended for management of varicella zoster virus ocular disease 3, 4
  • Monitor for complications including pseudodendrites, keratitis, corneal scarring, corneal vascularization, uveitis, sectoral iris atrophy, and secondary glaucoma 1
  • Monitor for dry eye and corneal anesthesia with neurotrophic keratitis 1, 2

Follow-Up Care

  • Schedule follow-up visit within 1 week of treatment initiation, including interval history, visual acuity measurement, slit-lamp biomicroscopy, and assessment for resolution of acute symptoms and development of complications 1, 2